PhaseBio Pharmaceuticals, Inc. (PHAS)
SBC to Revenue
20939.89%
TTM · Retrieved:
PHAS SBC to Revenue
Current (TTM)20939.89%retrieved
Current (TTM)20939.89%retrieved
PHAS TTM SBC/Revenue (20939.89% → 20939.89%)
Latest values, visible window
More history is needed to export this chart.
PHAS sbc to revenue history
Published TTM snapshot. The date records when this current TTM value was retrieved.
| Retrieved | SBC to Revenue |
|---|---|
| 20,939.8947% |